| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| KANILAD 100 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64251004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 100 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64251005 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 150 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64252001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 150 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64252002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 150 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64252003 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 150 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64252004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 150 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64252005 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 200 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64253001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 200 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64253002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 200 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64253003 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 200 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64253004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 200 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64253005 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250003 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANILAD 50 mg | LACOSAMIDUM | COMPR. FILM. | N03AX18 | W64250005 | MEDOCHEMIE LTD. - CIPRU | ||||||
| KANJINTI 150 mg | TRASTUZUMABUM | PULB. PT. CONC. PT. SOL. PERF. | L01FD01 | W65029001 | AMGEN EUROPE B.V. - OLANDA | X | |||||
| KANJINTI 420 mg | TRASTUZUMABUM | PULB. PT. CONC. PT. SOL. PERF. | L01FD01 | W65030001 | AMGEN EUROPE B.V. - OLANDA | X | |||||
| KANUMA 2 mg/ml | SEBELIPASE ALFA | CONC. PT. SOL. PERF. | A16AB14 | W69025001 | ALEXION EUROPE SAS - FRANTA | X |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman